ATT CEO Highlights BlueCollar Demand as AI Reshapes US Workforce
Tulsi Gabbard Resigns as Director of National IntelligenceWhat It Means for National Security and Markets
Stocks Edge Lower on Oil Price Volatility and Middle East Peace Deal Uncertainty PMI Data Awaited
Microsoft and Anthropic in Advanced Talks for AI Chip Collaboration Following 5 Billion Investment
Telecom CEO Warns Europe Risks Connectivity Blackout with Starlinks Satellite Dominance
Iran Intensifies Strategic Claims Over Strait of Hormuz with New Military Oversight Map
USCB Financial Holdings Inc Q1 2026 Earnings EPS Surpasses Estimates by 548 Amid Steady Performance
Kaltura Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency
MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Commodity Environment
NextNRG Inc Q1 2026 Earnings Narrowing Losses Exceed Expectations Amid Strategic Progress
BLNK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline
HIMX Q1 2026 Earnings Narrow EPS Beat in a Cautious Semiconductor Landscape
Rand Capital Edges Lower A Cautious Move Within Established Boundaries
NCS Multistage Holdings NCSM Eases Slightly as Traders Eye Key Support and Resistance Levels
OFS Capital Corporation 495 Notes due 2028 OFSSH Hold Steady at 239 as Market Awaits Direction
BRC Inc BRCC Declines 257 as Shares Approach Key Support Level
NerdWallet NRDS Gains 248 as Digital Personal Finance Platform Shows Resilience
Marvell Technology Shares Climb on AI Chip Demand Optimism
StoneX Group Q1 2026 Earnings EPS Surges Past Estimates with 365 Surprise
Trimble Inc TRMB Declines Nearly 3 Approaching Key Support at 5193
Microbot Medical MBOT Rallies Nearly 6 as Trading Volume Spikes
Ready Capital RC Shows Resilience Bounces from Support Eyes Resistance at 192
Golden Entertainment GDEN Holds Steady at 2855 as Support and Resistance Levels Come into Focus
Hayward Holdings Inc HAYW Gains Momentum Key Levels and What Lies Ahead
Lakeshore Acquisition III Corp Rights LCCCR Holds Steady at 024 Amid Limited Activity
Iovance Biotherapeutics IOVA Surges 5 Bulls Test Resistance at 451
TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels